Skip Nav Destination
Issues
February 2017
ISSN 2296-5270
EISSN 2296-5262
In this Issue
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2017, Vol. 40, No. 1-2
Beilage
Konsensusempfehlungen deutscher Experten - Management der Therapie mit Idelalisib
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (1-2): 1.
https://doi.org/10.1159/000458426
Editorial Board / Contents / Imprint
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (1-2): 1–6.
https://doi.org/10.1159/000456628
Original Article
Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations
Subject Area:
Oncology
Satoshi Igawa; Shiichiro Ryuge; Masaaki Ichinoe; Hiroyasu Nakashima; Sakiko Otani; Yoshiro Nakahara; Tomoya Fukui; Jiichiro Sasaki; Masaru Kubota; Masato Katagiri; Yoshiki Murakumo; Yukitoshi Satoh; Yuichi Sato; Noriyuki Masuda
Oncol Res Treat (2017) 40 (1-2): 7–13.
https://doi.org/10.1159/000455147
Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer
Subject Area:
Oncology
Yue-Ping Wan; Ming Xi; Hui-Chan He; Song Wan; Wei Hua; Zhao-Chang Zen; Yuan-Ling Liu; Yu-Lin Zhou; Ru-Jun Mo; Yang-Jia Zhuo; Hong-Wei Luo; Fu-Neng Jiang; Wei-De Zhong
Oncol Res Treat (2017) 40 (1-2): 15–20.
https://doi.org/10.1159/000455145
Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer
Subject Area:
Oncology
Julia Quidde; Laura Denne; Andreas Kutscheidt; Manfred Kindler; Andreas Kirsch; Melanie Kripp; Volker Petersen; Matthias Schulze; Jörg Seraphin; Dirk Tummes; Dirk Arnold; Alexander Stein
Oncol Res Treat (2017) 40 (1-2): 21–26.
https://doi.org/10.1159/000454774
Clinicopathological Features and Therapeutic Responses of Chinese Patients with Advanced Lung Adenocarcinoma Harboring an Anaplastic Lymphoma Kinase Rearrangement
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (1-2): 27–33.
https://doi.org/10.1159/000454715
Significance of Vasculogenic Mimicry Formation in Gastric Carcinoma
Subject Area:
Oncology
Jingfang Lv; Baocun Sun; Huizhi Sun; Yanhui Zhang; Junying Sun; Xiulan Zhao; Qiang Gu; Xueyi Dong; Na Che
Oncol Res Treat (2017) 40 (1-2): 35–41.
https://doi.org/10.1159/000455144
Relationship between Carnitine Pharmacokinetics and Fatigue in Patients Treated with Cisplatin-Containing Chemotherapy
Subject Area:
Oncology
Tomoaki Ikezaki; Kensuke Suzuki; Kenta Kambara; Minehiko Inomata; Seisuke Okazawa; Shinya Kajiura; Toshiro Miwa; Kouichi Tanabe; Tatsuhiko Kashii
Oncol Res Treat (2017) 40 (1-2): 42–45.
https://doi.org/10.1159/000455255
Novel Insights from Clinical Practice
A Case of Plasmablastic Lymphoma Achieving Complete Response and Durable Remission after Lenalidomide-Based Therapy
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (1-2): 46–48.
https://doi.org/10.1159/000455146
Society Bulletins
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (1-2): 50–56.
https://doi.org/10.1159/000455438
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (1-2): 57.
https://doi.org/10.1159/000456700
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (1-2): 58–61.
https://doi.org/10.1159/000456701
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (1-2): 63.
https://doi.org/10.1159/000456702
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (1-2): 64–68.
https://doi.org/10.1159/000456703
Meetings and Conferences
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (1-2): 70–71.
https://doi.org/10.1159/000456626
